OTCMKTS:ARSUF Fagron (ARSUF) Stock Price, News & Analysis $26.95 0.00 (0.00%) As of 11/19/2026 12:45 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChart About Fagron Stock (OTCMKTS:ARSUF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Fagron alerts:Sign Up Key Stats Today's Range$26.95▼$26.9550-Day Range$25.80▼$27.5052-Week Range$25.80▼$27.90Volume1,260 shsAverage Volume230 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield2.00%Price TargetN/AConsensus RatingN/A Company Overview Fagron is a pharmaceutical company focused on pharmaceutical compounding—the preparation of customized medicines to meet the needs of individual patients. It supplies pharmacies, hospitals, clinics and other healthcare providers with ingredients, products and services used to prepare compounded medications. The company’s offerings include active pharmaceutical ingredients and other compounding materials, finished formulations, equipment and packaging, as well as compounding services. These include sterile preparations and other customized medicines for healthcare settings. Founded in 1990, Fagron serves customers across Europe, North America, Latin America and other international markets. Its business combines product supply with specialized expertise and services supporting the preparation of personalized medicines.AI Generated. May Contain Errors. Read More Fagron Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks12th Percentile Overall ScoreARSUF MarketRank™: 0.60325938099 of 5 starsFagron scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Fagron. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Fagron is -18.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Fagron is -18.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares ShortedShort Interest Ratio / Days to CoverFagron has a short interest ratio ("days to cover") of 880.7, which indicates bearish sentiment.Change versus previous monthShort interest in Fagron has recently decreased by 29.67%, indicating that investor sentiment is improving significantly. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldFagron pays a meaningful dividend of 1.72%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthFagron does not have a long track record of dividend growth.Read more about Fagron's dividend. News and Social Media2.9 / 5News SentimentN/A News SentimentFagron has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.40 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Fagron this week, compared to 0 articles on an average week. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Fagron insiders have not sold or bought any company stock.Percentage Held by Institutions53.76% of the stock of Fagron is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Fagron's insider trading history. Receive ARSUF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fagron and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARSUF Stock News HeadlinesFagron (OTCMKTS:ARSUF) Share Price Crosses Above 200-Day Moving Average - Here's WhyNovember 20 at 3:02 AM | americanbankingnews.comFagron (OTCMKTS:ARSUF) Shares Up 2.4% - Here's What HappenedNovember 13, 2026 | americanbankingnews.comELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th. A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet.November 20 at 1:00 AM | Paradigm Press (Ad)Fagron shareholders approve all proposed resolutions at the General MeetingsMay 11, 2026 | globenewswire.comFagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026April 10, 2026 | globenewswire.comFagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growthApril 9, 2026 | globenewswire.comFagron NV (ARSUF) Q3 2025 Sales Call TranscriptOctober 9, 2025 | seekingalpha.comFagron delivers topline growth of 21.5% to €173 millionOctober 13, 2022 | finance.yahoo.comSee More Headlines ARSUF Stock Analysis - Frequently Asked Questions How have ARSUF shares performed this year? Fagron's stock was trading at $23.50 at the start of the year. Since then, ARSUF stock has increased by 14.7% and is now trading at $26.95. How do I buy shares of Fagron? Shares of ARSUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:ARSUF CIKN/A Webwww.fagron.com Phone32.8.001.28.80FaxN/AEmployees3,282Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (OTCMKTS:ARSUF) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | Sponsored6 Men Secretly Changed America’s Money. Now It’s Happening AgainIn 1910, six powerful men secretly met to lay the groundwork for the Federal Reserve, reshaping America's fina...Banyan Hill Publishing | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fagron NV Please log in to your account or sign up in order to add this asset to your watchlist. Share Fagron With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.